Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 28, 2023

SELL
$29.76 - $46.14 $197,576 - $306,323
-6,639 Reduced 24.03%
20,994 $682,000
Q1 2023

Apr 27, 2023

SELL
$38.09 - $57.79 $393,507 - $597,028
-10,331 Reduced 27.21%
27,633 $1.08 Million
Q4 2022

Feb 03, 2023

SELL
$40.54 - $56.2 $51,647 - $71,598
-1,274 Reduced 3.25%
37,964 $2.01 Million
Q3 2022

Oct 28, 2022

BUY
$36.98 - $49.2 $95,704 - $127,329
2,588 Added 7.06%
39,238 $1.77 Million
Q2 2022

Aug 04, 2022

SELL
$28.03 - $45.8 $88,126 - $143,995
-3,144 Reduced 7.9%
36,650 $1.34 Million
Q1 2022

Apr 26, 2022

SELL
$29.24 - $44.06 $10,409 - $15,685
-356 Reduced 0.89%
39,794 $1.65 Million
Q4 2021

Feb 18, 2022

BUY
$39.32 - $61.61 $1.58 Million - $2.47 Million
40,150 New
40,150 $1.71 Million

Others Institutions Holding SILK

About Silk Road Medical Inc


  • Ticker SILK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,565,600
  • Market Cap $1.03B
  • Description
  • Silk Road Medical, Inc. operates as a medical device company in the United States. The company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization. Its products include ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and initiate te...
More about SILK
Track This Portfolio

Track Efg Asset Management (North America) Corp. Portfolio

Follow Efg Asset Management (North America) Corp. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Efg Asset Management (North America) Corp., based on Form 13F filings with the SEC.

News

Stay updated on Efg Asset Management (North America) Corp. with notifications on news.